UBS OCONNOR LLC - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 134 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.23 and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS OCONNOR LLC ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q1 2015$784,000,000
-35.6%
50,000
-37.5%
0.02%
-19.0%
Q4 2014$1,217,000,000
-6.0%
80,000
-33.3%
0.02%
-4.5%
Q3 2014$1,294,000,000
-15.3%
120,000
+20.0%
0.02%
-26.7%
Q2 2014$1,527,000,000
-63.3%
100,000
-56.5%
0.03%
-62.0%
Q1 2014$4,158,000,000
+368.2%
230,000
+259.6%
0.08%
+393.8%
Q4 2013$888,000,000
-62.3%
63,959
-71.6%
0.02%
-67.3%
Q3 2013$2,358,000,000225,0000.05%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
RA Capital Management 6,000,000$66,540,0006.69%
FIC CAPITAL INC 787,529$8,734,0003.47%
RA Capital Management 1,220,209$13,532,0001.36%
PRINCETON CAPITAL MANAGEMENT INC 114,120$1,266,0000.67%
Perceptive Advisors 800,000$8,872,0000.53%
Cormorant Asset Management, LP 361,000$4,003,0000.53%
Highlander Capital Management, LLC 43,500$482,0000.43%
APEX CAPITAL, LLC 439,900$4,878,0000.42%
WASATCH ADVISORS LP 3,091,386$34,283,0000.37%
Baker Brothers Advisors 3,230,932$35,831,0000.31%
View complete list of SANGAMO THERAPEUTICS INC shareholders